Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vascular response patterns to targeted therapies in murine breast cancer models with divergent degrees of malignancy.
Hoffmann E, Gerwing M, Krähling T, Hansen U, Kronenberg K, Masthoff M, Geyer C, Höltke C, Wachsmuth L, Schinner R, Hoerr V, Heindel W, Karst U, Eisenblätter M, Maus B, Helfen A, Faber C, Wildgruber M. Hoffmann E, et al. Among authors: schinner r. Breast Cancer Res. 2023 May 23;25(1):56. doi: 10.1186/s13058-023-01658-9. Breast Cancer Res. 2023. PMID: 37221619 Free PMC article.
Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
Brill R, Uller W, Huf V, Müller-Wille R, Schmid I, Pohl A, Häberle B, Perkowski S, Funke K, Till AM, Lauten M, Neumann J, Güttel C, Heid E, Ziermann F, Schmid A, Hüsemann D, Meyer L, Sporns PB, Schinner R, Schmidt VF, Ricke J, Rössler J, Kapp FG, Wohlgemuth WA, Wildgruber M. Brill R, et al. Among authors: schinner r. Int J Cancer. 2021 May 1;148(9):2345-2351. doi: 10.1002/ijc.33406. Epub 2020 Dec 3. Int J Cancer. 2021. PMID: 33231291 Free article.
Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial.
Shuen TWH, Alunni-Fabbroni M, Öcal E, Malfertheiner P, Wildgruber M, Schinner R, Pech M, Benckert J, Sangro B, Kuhl C, Gasbarrini A, Chow PKH, Toh HC, Ricke J. Shuen TWH, et al. Among authors: schinner r. Clin Cancer Res. 2022 Sep 1;28(17):3890-3901. doi: 10.1158/1078-0432.CCR-22-0569. Clin Cancer Res. 2022. PMID: 35763041 Free PMC article. Clinical Trial.
Clinical Outcome and Quality of Life of Multimodal Treatment of Extracranial Arteriovenous Malformations: The APOLLON Study Protocol.
Schmidt VF, Masthoff M, Vielsmeier V, Seebauer CT, Cangir Ö, Meyer L, Mükke A, Lang W, Schmid A, Sporns PB, Brill R, Wohlgemuth WA, da Silva NPB, Seidensticker M, Schinner R, Küppers J, Häberle B, Haubner F, Ricke J, Zenker M, Kimm MA, Wildgruber M; APOLLON investigators. Schmidt VF, et al. Among authors: schinner r. Cardiovasc Intervent Radiol. 2023 Jan;46(1):142-151. doi: 10.1007/s00270-022-03296-8. Epub 2022 Oct 19. Cardiovasc Intervent Radiol. 2023. PMID: 36261507 Free PMC article.
Multiparametric MRI enables for differentiation of different degrees of malignancy in two murine models of breast cancer.
Gerwing M, Hoffmann E, Kronenberg K, Hansen U, Masthoff M, Helfen A, Geyer C, Wachsmuth L, Höltke C, Maus B, Hoerr V, Krähling T, Hiddeßen L, Heindel W, Karst U, Kimm MA, Schinner R, Eisenblätter M, Faber C, Wildgruber M. Gerwing M, et al. Among authors: schinner r. Front Oncol. 2022 Nov 2;12:1000036. doi: 10.3389/fonc.2022.1000036. eCollection 2022. Front Oncol. 2022. PMID: 36408159 Free PMC article.
Profiling specific cell populations within the inflammatory tumor microenvironment by oscillating-gradient diffusion-weighted MRI.
Hoffmann E, Gerwing M, Niland S, Niehoff R, Masthoff M, Geyer C, Wachsmuth L, Wilken E, Höltke C, Heindel WL, Hoerr V, Schinner R, Berger P, Vogl T, Eble JA, Maus B, Helfen A, Wildgruber M, Faber C. Hoffmann E, et al. Among authors: schinner r. J Immunother Cancer. 2023 Mar;11(3):e006092. doi: 10.1136/jitc-2022-006092. J Immunother Cancer. 2023. PMID: 36918222 Free PMC article.
Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer.
Kästle S, Stechele MR, Richter L, Schinner R, Öcal E, Alunni-Fabbroni M, De Toni E, Corradini S, Seidensticker M, Goldberg SN, Ricke J, Wildgruber M, Kimm MA. Kästle S, et al. Among authors: schinner r. J Cancer Res Clin Oncol. 2023 Sep;149(12):9777-9786. doi: 10.1007/s00432-023-04875-z. Epub 2023 May 29. J Cancer Res Clin Oncol. 2023. PMID: 37247078 Free PMC article.
Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M, Link H, Hirner-Eppeneder H, Alunni-Fabbroni M, Wildgruber M, Salvermoser L, Corradini S, Schinner R, Ben Khaled N, Rössler D, Galun E, Goldberg SN, Ricke J, Kazmierczak PM. Stechele M, et al. Among authors: schinner r. Radiat Oncol. 2023 Jul 28;18(1):125. doi: 10.1186/s13014-023-02316-2. Radiat Oncol. 2023. PMID: 37507808 Free PMC article.
39 results